IBX.AX实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 12:50):

Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy...

Stats
今日成交量	13 188.00
平均成交量	37 506.00
市值	2.42M
EPS	$0 ( 2024-04-30 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.170
ATR14	$0.00700 (9.46%)

音量相关性

長: -0.24 (neutral)

短: -0.39 (neutral)

Signal:(31.809) Neutral

Imagion Biosystems Ltd 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Imagion Biosystems Ltd 相关性 - 货币/商品

-0.86
( strong negative )

-0.45
( neutral )

0.00
( neutral )

-0.52
( weak negative )

0.83
( strong )

Imagion Biosystems Ltd 财务报表

Annual	2023
营收:	$1.65M
毛利润:	$-3.61M (-219.14 %)
EPS:	$-0.400

FY	2023
营收:	$1.65M
毛利润:	$-3.61M (-219.14 %)
EPS:	$-0.400

FY	2022
营收:	$473 429
毛利润:	$-3.14M (-663.76 %)
EPS:	$-0.350

FY	2021
营收:	$232 865
毛利润:	$232 865 (100.00 %)
EPS:	$-0.00806

Financial Reports:

No articles found.

Imagion Biosystems Ltd

Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer. Imagion Biosystems Limited has a collaborative research program with Patrys Limited to use the combined technologies for enhancing brain tumor imaging and diagnosis; and a joint development agreement with Global Cancer Technology, Inc. to develop GCT's novel nanoscintillator technology for the treatment of breast cancer. The company was incorporated in 2016 and is based in San Diego, California.